Oral triazolam sedation in implant dentistry.
Goodchild
Jason H
JH
D000284:Administration, Oral; D000766:Anesthesia, Dental / Q000379:methods*; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D019072:Antibiotic Prophylaxis / Q000009:adverse effects; D017963:Azithromycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D001711:Biotransformation; D016292:Procedural Sedation / Q000009:adverse effects / Q000379:methods; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003758:Dental Implantation, Endosseous; D004347:Drug Interactions; D006801:Humans; D018942:Macrolides / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D011229:Preanesthetic Medication / Q000009:adverse effects; D014229:Triazolam / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics
D014151:Anti-Anxiety Agents; D000900:Anti-Bacterial Agents; D018942:Macrolides; D014229:Triazolam; D017963:Azithromycin; D003577:Cytochrome P-450 Enzyme System; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A